- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- Resource Library
- Mental Health Disorders
- Agitation
- Anxiety Disorders
- Bipolar Disorder
- Cognition
- Depression
- Eating Disorders
- Personality Disorders
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Neuroscience
- Payer & Financing Models
- Quality Standards & Performance Measures
- Stigma
- Suicide Awareness
- Wellness
- Collections
- Featured
- Monthly Spotlight
- Psychopharmacology
- Learning Tracks
- Community Insights
- Community Podcast
- Disease Management & Support Tools
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Patient & Caregiver Resource Center
- PsychU Roleplay
- Psychiatric Scales
- PsychUSim
- Events
Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics
This is a Virtual Event for PsychU members in D.C., Maryland, North Carolina, South Carolina and Virginia.
In “Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics,” the objectives of this presentation are to understand the impact of mood episode recurrence in bipolar I disorder on patient functioning and clinical outcomes, discuss risk factors for mood episode recurrence, including nonadherence, in patients with bipolar I disorder, and review management strategies, including long-acting injectable antipsychotics (LAIs), to optimize patient outcomes in bipolar I disorder.
Featuring
Dennis Sholler, PhD (OPDC)
Clinical & Scientific Liaison
Amica Simmons-Yon, PharmD, PhD (OPDC)
Clinical & Scientific Liaison
Miranda Fisher, PhD (OPDC)
Clinical & Scientific Liaison
Speakers Dennis Sholler, PhD; Amica Simmons-Yon, PharmD, PhD; and Miranda Fisher, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
-
Virtual Event – Trace Amine-Associated Receptor 1 (TAAR1): A Potential New Target For The Treatment of Schizophrenia
February 14 3:00 pm to 4:00 pm
Registration
Related Resources
-
PsychU Brochure 2023
Downloadable Resource January 31, 2023Download Brochure
-
Pharmacokinetics, Plasma Concentrations (Their) & Clinical Relevance
On-Demand Webinar January 26, 2023Pharmacokinetics refers to the study of how drugs are processed by the body. These processes play an important role in mental health treatments, and can vary due to several factors,…
-
The Holidays – A Time For Silver, Gold, and… The Blues?
Podcast January 17, 2023Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on The Holiday Blues with special guest, Bennett Doughty, PharmD, BCPS, BCPP. During this…
Stay Connected: